Contacts

Prof. Giuseppe Opocher
Scientific Director IOV
Project manager
e-mail: direzionescientifica@iov.veneto.it
tel. 049 821 5644 I 7418

Dott.ssa Annarosa del Mistro
IOV Referent for WP 5
Project coordinator for the IOV-IRCCS
e-mail: annarosa.delmistro@iov.veneto.it
tel. 049 821 5872

Dott.ssa Arcangela De Nicolo
IOV Referent for WP 6
arcangela.denicolo@iov.veneto.it

Prof. Antonio Rosato
IOV Referent for WP 9
antonio.rosato@unipd.it

Dott. Alberto Bortolami
IOV Referent for WP 10
alberto.bortolami@iov.veneto.it

Grant office
grantoffice@iov.veneto.it
tel. 049 821 5187

In the European Union, cancer continues to represent one of the main challenges for public health. In the last 8 years, activities to combat this disease have been intensified in several respects, but some important issues remain unresolved.

The Innovative Partnership for Action Against Cancer – iPAAC, selected for funding under the Third Health Programme 2014–2020, aims to build upon the outcomes of previous EPAAC and CANCON Joint Actions. The IOV-IRCCS is among the 8 Italian institutions that collaborate with the Istituto Superiore di Sanità (one of the 24 beneficiaries of the grant agreement) through participation in the following work packages:

  • WP 5: Cancer prevention
  • WP 6: Genomics in cancer control and care
  • WP 9: Innovative therapies in cancer
  • WP 10: Governance of integrated and comprehensive cancer care

Objectives

The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. They include:

  • advances in the field of prevention;
  • global approaches to the use of genomics in cancer control;
  • enhancement of information systems and cancer registers;
  • improving care with a focus on major challenges;
  • anticipation of the upcoming challenges in terms of innovative therapies and the management of integrated cancer control, including a new analysis of national cancer plans.

Expected results

  • Support to member countries in the implementation at regional and local level of the recommendations of iPAAC and CANCON;
  • strengthening of cancer prevention;
  • greater effectiveness in the management of neglected tumors;
  • support for the introduction of immunotherapies;
  • evaluation of cancer care in member countries;
  • support for legislators involved in governance;
  • strengthening of information systems on a population basis.